Baxter EBITDA Margin 2010-2025 | BAX

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Baxter (BAX) over the last 10 years. The current EBITDA margin for Baxter as of March 31, 2025 is .
Baxter EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $10.77B $1.41B 13.04%
2024-12-31 $10.64B $1.49B 13.97%
2024-09-30 $9.54B $1.51B 15.82%
2024-06-30 $9.44B $1.93B 20.41%
2024-03-31 $9.34B $1.64B 17.51%
2023-12-31 $10.36B $1.69B 16.32%
2023-09-30 $8.97B $0.68B 7.54%
2023-06-30 $9.98B $0.97B 9.75%
2023-03-31 $9.86B $1.28B 13.00%
2022-12-31 $10.06B $1.38B 13.75%
2022-09-30 $13.79B $1.96B 14.24%
2022-06-30 $13.40B $2.11B 15.77%
2022-03-31 $12.91B $2.15B 16.68%
2021-12-31 $12.15B $2.22B 18.25%
2021-09-30 $12.45B $2.59B 20.81%
2021-06-30 $12.20B $2.55B 20.91%
2021-03-31 $11.82B $2.46B 20.78%
2020-12-31 $11.67B $2.46B 21.04%
2020-09-30 $11.53B $2.58B 22.39%
2020-06-30 $11.41B $2.60B 22.80%
2020-03-31 $11.53B $2.63B 22.77%
2019-12-31 $11.36B $2.59B 22.81%
2019-09-30 $11.14B $2.42B 21.70%
2019-06-30 $11.05B $2.30B 20.82%
2019-03-31 $11.06B $2.31B 20.85%
2018-12-31 $11.10B $2.36B 21.22%
2018-09-30 $11.08B $2.26B 20.40%
2018-06-30 $11.02B $2.16B 19.62%
2018-03-31 $10.79B $2.12B 19.61%
2017-12-31 $10.58B $2.04B 19.26%
2017-09-30 $10.43B $2.07B 19.80%
2017-06-30 $10.28B $1.97B 19.18%
2017-03-31 $10.26B $1.72B 16.71%
2016-12-31 $10.16B $1.55B 15.20%
2016-09-30 $10.12B $1.39B 13.68%
2016-06-30 $10.05B $1.30B 12.97%
2016-03-31 $9.94B $1.31B 13.14%
2015-12-31 $9.97B $1.21B 12.12%
2015-09-30 $10.15B $1.26B 12.36%
2015-06-30 $10.38B $1.27B 12.21%
2015-03-31 $12.06B $1.90B 15.78%
2014-12-31 $13.50B $2.53B 18.75%
2014-09-30 $15.03B $2.75B 18.28%
2014-06-30 $16.03B $3.29B 20.51%
2014-03-31 $15.55B $3.39B 21.79%
2013-12-31 $15.15B $3.38B 22.30%
2013-09-30 $14.33B $3.47B 24.23%
2013-06-30 $14.09B $3.57B 25.30%
2013-03-31 $14.00B $3.51B 25.09%
2012-12-31 $13.94B $3.48B 24.99%
2012-09-30 $14.03B $3.57B 25.47%
2012-06-30 $14.03B $3.54B 25.21%
2012-03-31 $14.00B $3.58B 25.58%
2011-12-31 $13.89B $3.62B 26.03%
2011-09-30 $13.80B $3.53B 25.56%
2011-06-30 $13.54B $3.56B 26.27%
2011-03-31 $13.20B $3.43B 25.95%
2010-12-31 $12.84B $2.82B 21.97%
2010-09-30 $12.82B $3.02B 23.60%
2010-06-30 $12.74B $2.97B 23.30%
2010-03-31 $12.67B $3.00B 23.70%
2009-12-31 $12.56B $3.52B 27.98%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $15.380B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.329B 27.82
Boston Scientific (BSX) United States $151.540B 37.94
Stryker (SYK) United States $146.015B 30.53
EssilorLuxottica (ESLOY) France $127.709B 0.00
Medtronic (MDT) Ireland $109.786B 15.56
Lonza Group Ag (LZAGY) Switzerland $49.554B 0.00
Haleon (HLN) United Kingdom $49.214B 28.03
ResMed (RMD) United States $36.648B 27.53
Agilent Technologies (A) United States $32.650B 21.28
GE HealthCare Technologies (GEHC) United States $32.569B 15.46
Terumo (TRUMY) Japan $26.857B 34.88
Insulet (PODD) United States $22.464B 88.18
Koninklijke Philips (PHG) Netherlands $21.600B 15.53
Zimmer Biomet Holdings (ZBH) United States $18.095B 11.62
Smith & Nephew SNATS (SNN) United Kingdom $12.819B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.043B 21.03
Lantheus Holdings (LNTH) United States $5.509B 13.90
Prestige Consumer Healthcare (PBH) United States $4.190B 18.72
Perrigo (PRGO) Ireland $3.610B 9.15
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.346B 15.24
ICU Medical (ICUI) United States $3.233B 23.84
Envista Holdings (NVST) United States $3.178B 26.41
GN Store Nord (GNNDY) Denmark $2.155B 17.85
QuidelOrtho (QDEL) United States $2.102B 14.46
LeMaitre Vascular (LMAT) United States $1.865B 41.69
AtriCure (ATRC) United States $1.729B 0.00
Acuren (TIC) United States $1.228B 0.00
AdaptHealth (AHCO) United States $1.196B 12.14
Green Thumb Industries (GTBIF) United States $1.101B 24.76
Neogen (NEOG) United States $1.077B 13.78
BioLife Solutions (BLFS) United States $1.046B 0.00
Kestra Medical Technologies (KMTS) United States $1.016B 0.00
Phibro Animal Health (PAHC) United States $0.972B 12.42
InMode (INMD) Israel $0.931B 9.38
Evolus (EOLS) United States $0.632B 0.00
CeriBell (CBLL) United States $0.619B 0.00
Curaleaf Holdings (CURLF) Canada $0.571B 0.00
Capricor Therapeutics (CAPR) United States $0.564B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.563B 0.00
Valneva SE (VALN) France $0.523B 0.00
Owens & Minor (OMI) United States $0.515B 4.27
Surmodics (SRDX) United States $0.429B 0.00
Tilray Brands (TLRY) Canada $0.412B 0.00
VAREX IMAGING (VREX) United States $0.340B 12.52
SNDL (SNDL) Canada $0.339B 0.00
Aurora Cannabis (ACB) Canada $0.313B 55.70
SEMPERIT AG HLD (SEIGY) Austria $0.291B 0.00
Cerus (CERS) United States $0.275B 0.00
Viemed Healthcare (VMD) United States $0.272B 22.90
Sanara MedTech (SMTI) United States $0.260B 0.00
ZimVie (ZIMV) United States $0.255B 11.61
Cresco Labs (CRLBF) United States $0.250B 0.00
Canopy Growth (CGC) Canada $0.239B 0.00
Sanuwave Health (SNWV) United States $0.231B 0.00
OraSure Technologies (OSUR) United States $0.217B 0.00
Quanterix (QTRX) United States $0.217B 0.00
Verano Holdings (VRNOF) United States $0.205B 0.00
Brainsway (BWAY) Israel $0.198B 52.30
Omeros (OMER) United States $0.196B 0.00
TriSalus Life Sciences (TLSI) United States $0.195B 0.00
Biote (BTMD) United States $0.194B 5.45
High Tide (HITI) Canada $0.188B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.80
Organigram Global (OGI) Canada $0.179B 0.00
Exagen (XGN) United States $0.157B 0.00
FitLife Brands (FTLF) United States $0.136B 16.72
Vireo Growth (VREOF) United States $0.125B 0.00
Jin Medical (ZJYL) China $0.121B 0.00
Veru (VERU) United States $0.096B 0.00
MacroGenics (MGNX) United States $0.095B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
Quipt Home Medical (QIPT) United States $0.092B 0.00
Fonar (FONR) United States $0.090B 11.56
TerrAscend (TSNDF) Canada $0.089B 0.00
Agape ATP (ATPC) $0.077B 0.00
InterCure (INCR) Israel $0.069B 0.00
Zynex (ZYXI) United States $0.065B 0.00
Apyx Medical (APYX) United States $0.063B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Modular Medical (MODD) United States $0.045B 0.00
United-Guardian (UG) United States $0.038B 13.02
Nephros (NEPH) United States $0.035B 47.43
Rockwell Medical (RMTI) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
Cellectar Biosciences (CLRB) United States $0.021B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00